Overview

Sida/Sweden nominates and finances a representative of the International Vaccine Institute (IVI) Board of Trustees. The financing covers travel and salary costs for the representative of Sweden at the Board meetings (2 physical meetings and four-five phone meeting per year). IVI has a mandate in the development of vaccins to poverty related diseases. The Swedish nominee needs thorough knowledge in drug discovery and development from both academia and industry, as well as knowledge of Sweden's p…

Involved parties

:
-
:
Not applicable
:
Sida
:
  • D01 - Donor country personnel

Strategies governing the contribution

  1. Research cooperation 2015-2022364,399 SEK 66.61% of total
  2. Research cooperation 2022-2028182,691 SEK 33.39% of total

Geographical allocation of the contribution

No countries have been assigned to this contribution.

Development areas for the contribution

No development areas have been assigned to this contribution.

Duration of the contribution

January 1, 2019
February 28, 2025
Closed

Committed and disbursed amount

Agreed amount SEK 547,090

Paid amount SEK 547,090

Paid per year (net value)

  • 2019: SEK 127,889
  • 2020: SEK 53,169
  • 2021: SEK 97,564
  • 2022: SEK 200,022
  • 2023: SEK 39,664
  • 2024: SEK 20,708
  • 2025: SEK 8,073

Sustainable Development Goals

The contributions contribution to the UN's global sustainability goals.

  • Global Goals, goal 3: Good health and well-being